PUBMED FOR HANDHELDS

Journal Abstract Search


300 related items for PubMed ID: 5130857

  • 1. [Immunosuppressive therapy in nephrotic syndrome and in chronic nephropathies in children].
    Cvorić A, Nikolić V.
    Srp Arh Celok Lek; 1971; 98(9):1133-45. PubMed ID: 5130857
    [No Abstract] [Full Text] [Related]

  • 2. [Immunosuppresive agents in the treatment of nephropathies of children].
    Schwalbová M, Krajci-Lazáryová M, Misíková Z.
    Bratisl Lek Listy; 1969 Feb; 51(2):198-205. PubMed ID: 5779177
    [No Abstract] [Full Text] [Related]

  • 3. [Childhood nephrotic syndrome with minimun glomerular lesions (clinical development and therapeutic response in 40 cases)].
    Ruilope LM, Casado S, López de Novales E, Barat A, Alvarez J, Hernando L.
    Rev Clin Esp; 1973 Nov 30; 131(4):313-8. PubMed ID: 4772782
    [No Abstract] [Full Text] [Related]

  • 4. [Indications and limitations of immunosuppressive therapy in chronic glomerulonephritis].
    Ponticelli C, Brancaccio D, Locatelli F, Imbasciati E.
    Minerva Nefrol; 1969 Nov 30; 16(3):228-34. PubMed ID: 5356052
    [No Abstract] [Full Text] [Related]

  • 5. Immunosuppressive therapy. 2.
    Skinner MD, Schwartz RS.
    N Engl J Med; 1972 Aug 10; 287(6):281-6. PubMed ID: 4556903
    [No Abstract] [Full Text] [Related]

  • 6. [Our experiences in the treatment of various chronic nephropathies using immunosuppressive agents].
    Mazdrakov G, Cukanov K.
    Nar Zdrav; 1973 Aug 10; 29(2):38-42. PubMed ID: 4793472
    [No Abstract] [Full Text] [Related]

  • 7. [Verification of indications for kidney biopsy in children with steroid-dependent nephrotic syndrome].
    Idczak-Nowicka E, Ksiazek J, Kryński J, Wyszyńska T.
    Pediatr Pol; 1996 Aug 10; 71(8):679-83. PubMed ID: 8927471
    [Abstract] [Full Text] [Related]

  • 8. [The use of chlorambucil in the nephrotic syndrome (NS) with frequent recurrences in children].
    Ciardi MR, Ginevri F, Perfumo F, Gusmano R.
    Minerva Nefrol; 1979 Aug 10; 26(4):495-600. PubMed ID: 542219
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment with immunosuppressive drugs in primary nephrotic syndromes in the pediatric age. Clinical studies].
    Varese LA.
    Minerva Pediatr; 1971 Feb 11; 23(6):262-6. PubMed ID: 5574180
    [No Abstract] [Full Text] [Related]

  • 10. [Experience with immunosuppressive therapy in 13 children with kidney diseases].
    Dibelková M, Misarová Z, Holotová J.
    Cesk Pediatr; 1970 May 11; 25(5):213-6. PubMed ID: 5443743
    [No Abstract] [Full Text] [Related]

  • 11. [Recommendations for immunosuppressive therapy of childhood glomerular kidney diseases].
    Bläker F.
    Monatsschr Kinderheilkd (1902); 1972 Jun 11; 120(6):252. PubMed ID: 5055849
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of nephrotic syndrome of children with immunosuppressive agents (literature survey)].
    Sergeeva KM, Grinbaum NB.
    Vopr Okhr Materin Det; 1975 Nov 11; 20(11):46-9. PubMed ID: 1220157
    [No Abstract] [Full Text] [Related]

  • 13. [Immunodepressive therapy in nephropathies].
    Zosin C, Mănescu N, Iacob G, Schwarzkopf A, Sabo I, Gluhovschi G.
    Stud Cercet Med Interna; 1969 Nov 11; 10(2):137-46. PubMed ID: 5344003
    [No Abstract] [Full Text] [Related]

  • 14. Drug therapy. Immunosuppressive agents. I.
    Kaplan SR, Calabresi P.
    N Engl J Med; 1973 Nov 01; 289(18):952-5. PubMed ID: 4582749
    [No Abstract] [Full Text] [Related]

  • 15. [Immunosuppressive treatment of glomerulonephritis and nephrotic syndrome].
    Stojimirović B.
    Med Glas; 1971 Nov 01; 25(7):273-6. PubMed ID: 5148090
    [No Abstract] [Full Text] [Related]

  • 16. [Results of immunosuppressive treatment of nephrotic syndrome].
    Przybyl L, Salwa-Kubasik W, Urbański K, Wróz M, Hryniewiecki J.
    Pol Tyg Lek; 1973 Jun 25; 28(26):990-3. PubMed ID: 4727614
    [No Abstract] [Full Text] [Related]

  • 17. Immunosuppressive treatment of nephrotic syndrome.
    Orlowski T, Wojtulewicz-Kurkus J, Glyda J, Kunert Z.
    Pol Med J; 1969 Jun 25; 8(3):552-71. PubMed ID: 4186260
    [No Abstract] [Full Text] [Related]

  • 18. [Glomerular permeability of plasma-proteins and therapy of nephrotic syndrome].
    Brancaccio D, Locatelli F, Ponticelli C, Imbasciati E.
    Minerva Nefrol; 1969 Jun 25; 16(3):223-7. PubMed ID: 5356051
    [No Abstract] [Full Text] [Related]

  • 19. Should cyclosporine replace cytoxan or chlorambucil as the second-line drug for steroid-dependent nephrotic syndrome?
    Brouhard BH.
    Semin Nephrol; 1998 May 25; 18(3):367-9. PubMed ID: 9613881
    [No Abstract] [Full Text] [Related]

  • 20. Management of the nephrotic syndrome.
    Linshaw MA, Gruskin AB.
    Clin Pediatr (Phila); 1974 Jan 25; 13(1):45-51. PubMed ID: 4588668
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.